Death during intensive glycemic therapy of diabetes: Mechanisms and implications

American Journal of Medicine

Volumn 124, Issue 11, 2011, Pages 993-996

  Cryer, Philip E ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; METFORMIN; SULFONYLUREA;

ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CAUSE OF DEATH; COMORBIDITY; DEATH; DIABETES MELLITUS; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INTENSIVE CARE; INTENSIVE GLYCEMIC THERAPY; MALNUTRITION; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 80054967262     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2011.08.008     Document Type: Editorial

References (61)

1. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 1993 977 986
2. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 1998 837 853
3. UK Prospective Diabetes Study (UKPDS) Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 352 1998 854 865
4. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes N Engl J Med 353 2005 2643 2653
5. R.R. Holman, S.K. Paul, M.A. Bethel, D.R. Matthews, and H.A. Neil 10-year follow-up of intensive glucose control in type 2 diabetes N Engl J Med 359 2008 1577 1589
6. The Action to Control Cardiovascular Risk in Diabetes Study Group Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 358 2008 2545 2559
7. The ADVANCE Collaborative Group Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 358 2008 2560 2572
8. W. Duckworth, C. Abraira, and T. Moritz Glucose control and vascular complications in veterans with type 2 diabetes N Engl J Med 360 2009 129 139
9. The NICE-SUGAR Study Investigators Intensive versus conventional glucose control in critically ill patients N Engl J Med 360 2009 1283 1297
10. B.P. Kavanagh, and K.C. McCowen Glycemic control in the ICU N Engl J Med 363 2010 2540 2546
11. D. Kansagara, R. Fu, M. Freeman, F. Wolf, and M. Helfand Intensive insulin therapy in hospitalized patients: a systematic review Ann Intern Med 154 2011 268 282
12. M. Bliss The Discovery of Insulin 1984 University of Chicago Press Chicago, IL
13. R.N. Auer Progress review: hypoglycemic brain damage Stroke 17 1986 699 708 (Pubitemid 16066542)
14. D.D. Clarke, and L. Sokoloff Circulation and energy metabolism of the brain G. Siegel, B. Agranoff, R.T. Albers, P. Molinoff, Basic Neurochemistry: Molecular, Cellular and Medical Aspects 5th ed. 1994 Raven Press New York, NY 645 680
15. S.W. Suh, K. Aoyama, and Y. Chen Hypoglycemic neuronal death and cognitive impairment are prevented by poly(ADP-ribose) polymerase inhibitors administered after hypoglycemia J Neurosci 23 2003 10681 10690 (Pubitemid 37485282)
16. T. Deckert, J.E. Poulsen, and M. Larsen Prognosis of diabetics with diabetes onset before the age of thirty-one I. Survival, causes of death, and complications Diabetologia 14 1978 363 370 (Pubitemid 8357140)
17. W.M.G. Tunbridge Factors contributing to deaths of diabetics under fifty years of age Lancet 2 1981 569 572 (Pubitemid 11052797)
18. S.P. Laing, A.J. Swerdlow, and S.D. Slater The British Diabetic Association Cohort Study, I: all-cause mortality in patients with insulin-treated diabetes mellitus Diabet Med 16 1999 459 465
19. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group Long-term effect of diabetes and its treatment on cognitive function N Engl J Med 356 2007 1842 1852
20. R.G. Feltbower, H.J. Bodansky, and C.C. Patterson Acute complications and drug misuse are important causes of death for children and young adults with type 1 diabetes Diabetes Care 31 2008 922 926
21. T. Skrivarhaug, H.-J. Bangstad, L.C. Stene, L. Sandvik, K.F. Hanssen, and G. Joner Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway Diabetologia 49 2006 298 305 (Pubitemid 43185398)
22. R.J. Tanenberg, C.A. Newton, and A.J. Drake III Confirmation of hypoglycemia in the "dead-in-bed" syndrome, as captured by a retrospective continuous glucose monitoring system Endocr Pract 16 2010 244 248
23. D. Goldman The electrocardiogram in insulin shock Arch Intern Med 66 1940 93 108
24. Y.R. Chelliah Ventricular arrhythmias associated with hypoglycaemia Anaesth Intensive Care 28 2000 698 700 (Pubitemid 32007687)
25. R.E. Ferner, and H.A. Neil Sulphonylureas and hypoglycaemia BMJ 296 1988 949 950 (Pubitemid 18093424)
26. J.E. Gerich Oral hypoglycemic agents N Engl J Med 321 1989 1231 1245 (Pubitemid 19273033)
27. A. Holstein, and E.H. Egberts Risk of hypoglycaemia with oral antidiabetic agents in patients with Type 2 diabetes Exp Clin Endocrinol Diabetes 111 2003 405 414 (Pubitemid 37486432)
28. S.S. Johnston, C. Conner, M. Aagren, D.M. Smith, J. Bouchard, and J. Brett Evidence linking hypoglycemic events to an increased risk of acute cardiovascular events in patients with type 2 diabetes Diabetes Care 34 2011 1164 1170
29. T.K. Schramm, G.H. Gislason, and A. Vaag Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study Eur Heart J 32 15 2011 1900 1908
30. 1c in people with type 2 diabetes: a retrospective cohort study Lancet 375 2010 481 489
31. 1 C and cardiovascular outcomes in type 2 diabetes Diabetes Care 34 2011 77 83
32. E.S. Huang, J.Y. Liu, H.H. Moffet, P.M. John, and A.J. Karter Glycemic control, complications, and death in older diabetic patients: the diabetes and aging study Diabetes Care 34 2011 1329 1336
33. M.C. Riddle, W.T. Ambrosius, and D.J. Brillon Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial Diabetes Care 33 2010 983 990
34. J.M. Lachin Point: intensive glycemic control and mortality in ACCORDa chance finding? Diabetes Care 33 2010 2719 2721
35. M.C. Riddle Counterpoint: intensive glucose control and mortality in ACCORDstill looking for clues Diabetes Care 33 2010 2722 2724
36. M.E. Miller, D.E. Bonds, and H.C. Gerstein The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study BMJ 340 2010 b5444
37. D.E. Bonds, M.E. Miller, and R.M. Bergenstal The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study BMJ 340 2010 b4909
38. The ACCORD Study Group Long-term effects of intensive glucose lowering on cardiovascular outcomes N Engl J Med 364 2011 818 828
39. J.S. Skyler Glycemia and cardiovascular diseases in type 2 diabetes J Intern Med 268 2010 468 470
40. S. Zoungas, A. Patel, and J. Chalmers Severe hypoglycemia and risks of vascular events and death N Engl J Med 363 2010 1410 1418
41. L. Boucai, W.N. Southern, and J. Zonszein Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities Am J Med 124 11 2011 1028 1035
42. E. Selvin, M.W. Steffes, and H. Zhu Glycated hemoglobin, diabetes and cardiovascular risk in nondiabetic adults N Engl J Med 362 2010 800 811
43. R. Pfister, S.J. Sharp, R. Luben, K.T. Khaw, and N.J. Wareham No evidence of an increased mortality risk associated with low levels of glycated haemoglobin in a non-diabetic UK population Diabetologia 54 2011 2025 2032
44. S.W. Suh, A.M. Hamby, and R.A. Swanson Hypoglycemia, brain energetics, and hypoglycemic neuronal death GLIA 55 2007 1280 1286 (Pubitemid 47235369)
45. P.E. Cryer Hypoglycemia, functional brain failure, and brain death J Clin Invest 117 2007 868 870 (Pubitemid 46556741)
46. C. Nordin The case for hypoglycaemia as a proarrhythmic event: basic and clinical evidence Diabetologia 53 2010 1552 1561
47. B.M. Frier, G. Schernthaner, and S.R. Heller Hypoglycemia and cardiovascular risks Diabetes Care 34 Suppl 2 2011 S132 S137
48. R.T. Robinson, N.D. Harris, R.H. Ireland, I.A. Macdonald, and S.R. Heller Changes in cardiac repolarization during clinical episodes of nocturnal hypoglycaemia in adults with type 1 diabetes Diabetologia 47 2004 312 315 (Pubitemid 38315368)
49. N.P. Murphy, M.E. Ford-Adams, and K.K. Ong Prolonged cardiac repolarisation during spontaneous nocturnal hypoglycaemia in children and adolescents with type 1 diabetes Diabetologia 47 2004 1940 1947 (Pubitemid 40110202)
50. G.V. Gill, A. Woodward, I.F. Casson, and P.J. Weston Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetesthe 'dead in bed' syndrome revisited Diabetologia 52 2009 42 45
51. P.E. Cryer Hypoglycemia in Diabetes: Pathophysiology, Prevalence and Prevention 2009 American Diabetes Association Alexandria, VA
52. G.K. Adler, I. Bonyhay, H. Failing, E. Waring, S. Dotson, and R. Freeman Antecedent hypoglycemia impairs autonomic cardiovascular function: implications for rigorous glycemic control Diabetes 58 2009 360 366
53. J.S. Skyler, R. Bergenstal, and R.O. Bonow Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials Diabetes Care 32 2009 187 192
54. V.M. Montori, and M. Fernández-Balsells Glycemic control in type 2 diabetes: time for an evidence-based about-face? Ann Intern Med 150 2009 803 808
55. J.S. Yudkin, B. Richter, and E.A.M. Gale Intensified glucose lowering in type 2 diabetes: time for a reappraisal Diabetologia 53 2010 2079 2085
56. R. Boussageon, T. Bejan-Angoulvant, and M. Saadatian-Elahi Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomized controlled trials BMJ 343 2011 d4169
57. P.E. Cryer Elimination of hypoglycemia from the lives of people affected by Diabetes Diabetes 60 2011 24 27
58. American Diabetes Association Standards of medical care in diabetes Diabetes Care 34 Suppl 1 2011 S11 S61
59. UK Hypoglycaemia Study Group Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration Diabetologia 50 2007 1140 1147
60. J.M. Lachin, S. Genuth, D.M. Nathan, B. Zinman, and B.N. Rutledge Effect of glycemic exposure on the risk of microvascular complications in the Diabetes Control and Complications Trialrevisited Diabetes 57 2008 995 1001
61. P. Gæde, P. Vedel, N. Larsen, G.V.H. Jensen, H.-H. Parving, and O. Pedersen Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes N Engl J Med 348 2003 383 393 (Pubitemid 36159355)